StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Diisopropylethylamine → 2-(4-Fluorophenyl)-6-(n-(2-hydroxyethyl)methylsulfonamido)-n-methyl-5-(3-(1-(pyridin-2-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide

HRID 1025109
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 1025109
Cl.Cl.[N:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[C:9]1([NH2:12])[CH2:11][CH2:10]1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.[F:46][C:47]1[CH:52]=[CH:51][C:50]([C:53]2[O:54][C:55]3[CH:65]=[C:64]([N:66]([CH2:71][CH2:72][OH:73])[S:67]([CH3:70])(=[O:69])=[O:68])[C:63]([C:74]4[CH:75]=[C:76]([CH:80]=[CH:81][CH:82]=4)[C:77](O)=[O:78])=[CH:62][C:56]=3[C:57]=2[C:58](=[O:61])[NH:59][CH3:60])=[CH:49][CH:48]=1>CN(C=O)C.CCOC(C)=O>[F:46][C:47]1[CH:52]=[CH:51][C:50]([C:53]2[O:54][C:55]3[CH:65]=[C:64]([N:66]([CH2:71][CH2:72][OH:73])[S:67]([CH3:70])(=[O:69])=[O:68])[C:63]([C:74]4[CH:82]=[CH:81][CH:80]=[C:76]([C:77](=[O:78])[NH:12][C:9]5([C:4]6[CH:5]=[CH:6][CH:7]=[CH:8][N:3]=6)[CH2:11][CH2:10]5)[CH:75]=4)=[CH:62][C:56]=3[C:57]=2[C:58]([NH:59][CH3:60])=[O:61])=[CH:49][CH:48]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 4

HCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 533931811-(2-Pyridyl)cyclopropylamine DihydrochlorideHCID 59275652HCID 59275652, Verbindung

Produkt 1

HCID 59275584
2-(4-Fluorophenyl)-6-(n-(2-hydroxyethyl)methylsulfonamido)-n-methyl-5-(3-(1-(pyridin-2-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide
Ausbeute 32,8 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6228DimethylformamideLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

1-(pyridin-2-yl)cyclopropanamine dihydrochloride (24 mg, 0.114 mmol) was added to a stirring solution of HATU (54 mg, 0.142 mmol), DIEA (50 μL, 0.285 mmol), and 3-(2-(4-fluorophenyl)-6-(N-(2-hydroxyethyl)methylsulfonamido)-3-(methylcarbamoyl)benzofuran-5-yl)benzoic acid (50 mg, 0.095 mmol) in DMF (950 μL) at rt. It was allowed to stir for 1 hour. The mixture was diluted with EtOAc and washed with sat NaHCO3, and sat NaCl. The organic phase was dried over Na2SO4, filtered and concentrated and was purified by preparative reverse phase HPLC on a C18 column using a suitably buffered H2O/CH3CN gradient, and concentrated to give the titled compound (20 mg, 32%). 1H NMR (500 MHz, DMSO-d6) d ppm 9.20 (1 H, s), 8.49-8.57 (1 H, m), 8.45 (1 H, d, J=3.97 Hz), 7.97-8.05 (3 H, m), 7.96 (1 H, s), 7.94 (1 H, d, J=7.93 Hz), 7.80 (1 H, d, J=7.93 Hz), 7.64-7.69 (1 H, m), 7.63 (1 H, s), 7.56 (1 H, t, J=7.63 Hz), 7.37-7.47 (3 H, m), 7.15 (1 H, dd, J=6.41, 4.88 Hz), 4.91 (1 H, br. s.), 3.51-3.60 (1 H, m), 3.22 (3 H, s), 2.89-2.98 (3 H, m), 2.81 (3 H, d), 1.50-1.60 (2 H, m), 1.23-1.33 (2 H, m). LC-MS retention time: 1.37 min; m/z (MH+): 643. LC data was recorded on a Shimadzu LC-10AS liquid chromatograph equipped with a Waters XBridge 5 u C18 4.6×50 mm column using a SPD-10AV UV-V is detector at a detector wave length of 220 nM. The elution conditions employed a flow rate of 5 ml/min, a gradient of 100% solvent A/0% solvent B to 0% solvent A/100% solvent B, a gradient time of 2 min, a hold time of 1 min, and an analysis time of 3 min where solvent A was 5% acetonitrile/95% H2O/10 mM ammonium acetate and solvent B was 5% H2O/95% acetonitrile/10 mM ammonium acetate. MS data was determined using a Micromass Platform for LC in electrospray mode. Additional HPLC method: Solvent A=5% CH3CN/95% H2O/0.1% TFA, Solvent B=95% CH3CN/5% H2O/0.1% TFA, Start % B=10, Final % B=100, Gradient time=15 min, Stop time=18 min, Flow Rate=1 ml/min. Column: Waters Sunfire C-18, 4.6×150 mm, 3.5 mm, Rt=7.17 min, purity=98%; Column: Waters Xbridge Phenyl column 4 6×150 mm, 3.5 mm, Rt=7.89 min, purity=99%.

Aufarbeitung

  1. washwashed
  2. dry with materialThe organic phase was dried over Na2SO4
  3. filtrationfiltered
  4. concentrationconcentrated
  5. customwas purified by preparative reverse phase HPLC on a C18 column
  6. concentrationconcentrated

Quellen und Nachweise

ORD-Eintrag
ord-1159f8a3af8b4574ac70ff363e284ae5
Quelldatensatz
uspto-grants-2014_05
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08722688B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion